Fragrant Snow pharmacy suspected falsely increases 500 million sales company buys the newspaper to extinguish fire

Guangdong pharmaceutical industry hidden for many years black secret due to the General pharmaceutical director Yong Yong was arrested after the punishment surfaced, "Brain tumor concept Unit" fragrant snow pharmaceutical sales tax invoices involved in it. In the media exposure to its alleged virtual increase in performance, fake listing, the fragrant snow pharmaceutical in the face of the public to continue to conceal the measures to launch a large area of "fire" action, in Beijing to buy a newspaper on the newsstand, China Network finance learned that the relevant personnel in the media units have been waiting for more than On the two-tier market, the first trading day after the Fragrant Snow Pharmaceutical Festival, the share price fell. Jian an tang falsely open invoices led by fragrant snow pharmaceutical financial fraud recently, the media received 3 report materials, mainly for the Guangdong pharmaceutical falsely open value-added tax invoice events, but inadvertently involved in fragrant snow pharmaceutical. April 25, 2012, general manager of Yong Yong was detained in criminal detention, in 2007, he entered the general manager of the pharmaceutical industry, and then with others to seize the company's assets. In the job before the general manager of Guangdong Pharmaceutical, Yong Yong was a general manager of the pharmaceutical industry. In the Yong Yong confession record, confessed to the pharmaceutical falsely open value-added tax invoice behavior, and for its provide invoices for the Canton Jian an Tang Pharmaceutical Co., Ltd. (hereinafter referred to as Jian an tang) and Guangzhou Ming Xin Pharmaceutical Co., Ltd. Jian an Tang chairman for Shelifa, when the police catch suspected sales tax invoices Shelifa, Shelifa escape has not yet been brought to justice. The informant revealed that to health Tang purchase invoices falsely increase the performance of more than one of the pharmaceutical industry, fragrant snow pharmaceutical also involved. According to its disclosure, Xiang-xue Pharmaceutical and jian an tang relationship is very unusual, "this circle is aware of the fragrant Snow Pharmaceutical Chairman Wang Yonghui and Shelley Hair Relationship, Shelifa is the key executive of Wang Yonghui, for fragrant snow pharmaceutical supply of medicinal herbs and the provision of value-added tax invoices." Shelifa control of Jian an tang and fragrant snow pharmaceutical complex, close contacts, Jian an tang is the first major supplier of fragrant snow pharmaceutical, is also a big customer of the fragrant snow pharmacy. According to the informer, since 2006, the health care Church has helped to buy and sell VAT invoices amounting to 50 million a year, totaling about 500 million. And it is Jian ' an tong to help the fragrant snow pharmaceutical falsely increase sales, help fragrant snow pharmaceutical whitewash financial data to achieve the listing purpose. Jian an tang and fragrant snow pharmaceutical mainly to buy and sell Chinese medicine, Jian ' an Tang 4 consecutive years is the first major supplier of fragrant snow pharmaceutical, 2008 is still the fourth largest customer of the fragrant snow pharmacy. 2007-2011 Jian an tang to fragrant snow pharmacy to provide Chinese herbal medicine amount is 5.6156 million yuan, 20.1487 million, 33.8613 million yuan, 33.2453 million yuan, 36.1668 million yuan respectively. These sources said that the cost of these purchases are divided into two types: one is the physical warehousing, and the other is a fictitious transaction, through health tang to fragrant snow pharmaceutical falsely open value-added tax invoices to manipulate, to whitewash the purpose of financial profit. Concrete operation, Jian an church has fixed cooperation invoicing side, these connections will invoice to sell Shelifa, and then by Shelifa resell to fragrant snow pharmacy. The people familiar with the matter said that the average monthly to achieve 100.03 billion sales, fragrant snow pharmaceutical will operate a sum of about 5 million yuan of false trading. Its revealed that fragrant snowIn the pharmaceutical sales records, some companies have never had sales, but suddenly one months and Shannon have millions of million or even tens of millions of sales, these are also bought and sold VAT invoices, not the real sales performance. Fragrant Snow Pharmaceutical 2010 years operating income of 513 million yuan, net profit of 75.42 million yuan, after whitewashing, 2012 revenue reached 801 million yuan, net profit of 107 million yuan, two-year performance growth of 42.7%. A senior insider in the IPO Circle said some enterprises in the early stage by means of the sale of sales, through different accounts to do the accounting, through invoicing discount, the company can falsely increase sales, hundreds of thousands of of the margin can pry move millions of of the operating income, such operations, financial statements are very beautiful, but the financial authenticity of a large discount. Suspected of concealing the relevant party after the listing of high premium mergers and acquisitions related party Shannon 2.5, has completed 11 acquisition projects (including the acquisition of Shanghai Qiao Pharmaceutical), the cumulative cost of 928 million yuan, to the majority of capital investment. But the whistleblower disclosed that the chairman Wang Yonghui concealed some of its undisclosed companies, listed, through the collection of capital mergers and acquisitions by a high premium to the listed companies. 2011, fragrant Snow pharmaceutical began to take drastic implementation of mergers and acquisitions, the nine polar organisms, Huazhou Chinese herbal Medicine factory, Guangdong Qing Ping Pharmaceutical Co., Ltd. (Qing-ping pharmaceutical) part of the assets and Zhongshan excellent bio-Technology Development Co., Ltd. (Paragon Biology) 90% Equity in the bag. 2012, Shannon continued to purchase the Guangzhou Baiyun Medical Plastic Co., Ltd. (Baiyun Medical Glue Company) 45% Equity, Guangdong Nine polar Daily Health Products Co., Ltd. (nine polar Daily health care products) and Hunan Spring nine modern Chinese Medicine Co., Ltd. (Spring Nine) 7.98% equity. 2013, fragrant snow pharmaceutical and then acquired the Guangzhou na Tai Bio-Pharmaceutical Technology Co., Ltd. (Na Tai Biological) and Shanghai Qiao Pharmaceutical industry. The informant pointed out that the above-mentioned acquisition of the target, nine polar organisms, nine-day health care products and Huazhou Traditional Chinese medicine factory actually early in Wang Yonghui under the command. And said these companies are Wang Yonghui sent to the company's staff to manage, the Director and general manager of the fragrant Snow pharmaceutical work for several years. But the company said it did not have a linked transaction with the companies. "Nine polar creature 100% is Wang Yonghui, 2007 is king, 2011 ago with nine polar creatures business is fragrant Snow's finance director Chen Wenjin, Finance Department manager Liu Zhiyan to contact, collect money also received snow finance, after the acquisition is only surface Kung Fu" The informer stated more details. A hundreds of pages of business data found a major flaw. April 19, 2011, nine-level organisms signed a company charter, the rules show that the nine-level biological shareholders for fragrant Snow pharmaceutical, the amount of investment is 15 million yuan, the investment time of January 31, 2007; it is doubtful that, at the same time period, the nine-level biology of a shareholder contribution information table, the investment time has become 2011 years , the latter is consistent with the fragrant Snow Pharmaceutical Bulletin, but two of the data are conflicting with each other. According to the "Gem Prospectus information Disclosure Content and format guidelines", issuedPedestrians should disclose the main shareholders holding more than 5% per cent of the issuer and other enterprises controlled by the actual controller. Among them, the controlling shareholder and the actual control person control the other enterprise situation mainly includes: the registered capital, the Paid-in capital, the registration place and the main production and Operation Place, the main business, the last year and the final net profit. And the fragrant Snow pharmacy prospectus conceals the related company which the actual control person has the important relation, according to the Supreme People's Court "regarding the trial securities market because of the false statement causes the civil compensation case" to belong to the information disclosure significant omission behavior. If the nine-level biology has long been in the Shannon Real control of the name, then, fragrant snow pharmaceutical is involved in the actual control of the relevant company information disclosure of major omissions, suspected of false statements, the 2011 37.5 million yuan mergers and acquisitions of nine-level biological fraud. In fact, fragrant snow pharmacy heavily received in the company benefit is not ideal, the risk of asset integration is self-evident. Investors are more skeptical that Shannon has been heavily betting on nearly 100 million yuan in nine polar organisms, two years have been difficult to see the nine-pole direct Sales licence application progress.